|
HS Code |
614205 |
| Product Name | Erythrinae Cortex Veterinary Grade API |
| Appearance | Brown to reddish-brown powder |
| Main Active Components | Isoflavonoids, Alkaloids |
| Intended Use | Veterinary pharmaceutical preparations |
| Formulations Supported | Tablets, Injections, Capsules, Powders, Granules, Premix, Solutions |
| Purity | ≥98% (by HPLC) |
| Moisture Content | ≤5% |
| Solubility | Partially soluble in water, soluble in ethanol |
| Storage Conditions | Store in cool, dry place away from light |
| Shelf Life | 24 months |
As an accredited Erythrinae Cortex Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Sealed aluminum foil bag or fiber drum, labeled, 25 kg net weight, moisture-proof and light-resistant, suitable for pharmaceutical veterinary manufacturing. |
| Shipping | The shipping for Erythrinae Cortex Veterinary Grade API is securely packed in sealed, moisture-proof, and tamper-evident containers. Standard packaging sizes include drums or cartons, with inner double-layer PE bags. The product is shipped via reliable courier or freight, ensuring compliance with international safety and handling regulations for pharmaceuticals. |
| Storage | Store Erythrinae Cortex Veterinary Grade API in a tightly sealed container, protected from light, moisture, and heat. Keep in a cool, dry, and well-ventilated area, ideally at room temperature (15-25°C). Avoid exposure to direct sunlight and incompatible substances. Ensure storage is secure and clearly labeled, and restrict access to authorized personnel only. Follow all relevant regulatory and safety guidelines. |
Applications of Erythrinae Cortex Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions in Industrial ManufacturingErythrinae Cortex veterinary grade API stands as a specialized herbal raw material supporting diverse pharmaceutical and feed additive applications across the livestock and animal health segment. Our vertically integrated supply focuses on real-world manufacturing scenarios, detailing usage within aquatic, swine, ruminant, and companion animal health solutions. The following reference applications reflect current industrial processes, regulatory frameworks, and practical formulation approaches required by downstream clients. 1. Aquaculture Antibacterial Oral PowdersIn the aquaculture industry, manufacturers incorporate Erythrinae Cortex API into medicated oral powders to manage pathogenic bacterial challenges in farmed fish and shrimp. Production aligns with strict veterinary medicinal directives governing water-dispersible agents, and manufacturers optimize inclusion levels based on farmed species’ weight and disease status. Integration demands precise milling and homogeneous blending with carrier starches to ensure dispersibility in water treatment systems. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Swine Injectable Preparations for Fever and Inflammation ControlCommercial swine health solution manufacturers employ this API to formulate injectable liquids targeting heat stress and febrile conditions. Quality teams comply with national pharmacopoeial standards and batch-release controls for parenteral veterinary products. The ingredient enters the sterile blending process following solution clarification and undergoes final filtration prior to vial filling under aseptic conditions. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Ruminant Compound Premixes for Livestock FeedMajor premix and feed manufacturers incorporate this botanical raw material into compound premixes designed for cattle and sheep to address specific health challenges such as digestive disorders or seasonal stress. Production requires precise dust control and blending validation, meeting both medicinal feed additive and general feed safety directives enforced by regional and export destination authorities. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Veterinary Capsule Formulations for Companion AnimalsAnimal pharmaceutical producers prepare standardized capsule formulations for canines and felines using this ingredient as part of anti-inflammatory and adjunct anti-anxiety regimens. Compliance with pharmaceutical-grade production requirements for small animal products guides each operation, and scale-up addresses batch consistency concerns unique to herbal APIs in fill-weight sensitive dosage forms. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Poultry Water-Soluble Solution ConcentratesVeterinary pharmaceutical factories formulate water-soluble solution concentrates for poultry operations as supportive agents during population-level stress events or to manage mild respiratory outbreaks. The process demands careful pH adjustment, homogeneity testing, and bottling under strict GMP-certified environments to meet withdrawal time and veterinary residue requirements for international poultry export markets. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Erythrinae Cortex Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Our roots in animal health manufacturing run deep, and Erythrinae Cortex has long interested both tradition-minded veterinarians and science-driven formulating chemists. Used for generations in herbal therapeutics, its reliable role comes from a recognizable phytochemical profile, supporting various health situations in livestock, pets, and companion animals. Today, our job as manufacturers is to ensure that the raw power of Erythrinae Cortex translates into predictable, measurable results in the finished veterinary products—tablets, injections, capsules, powders, granules, premixes, and solution forms.
Making this transition—plant to pharmaceutical—takes more than raw material extraction. Our dedicated production lines approach each API batch, not as an abstract bulk ingredient, but as a tangible solution for real-world animal care. We start with authenticated Erythrina variegata bark, sourced to minimize variability. The bark meets rigorous screening for pesticides and heavy metals before extraction ever starts. Our plant team, not a third-party contract operator, manages solvent selection, extraction temperature, and filtration, following a standard operating protocol shaped by daily experience and frequent improvement. What matters most is what each batch brings to the customer’s formula: purity, activity consistency, and batch-to-batch reproducibility. Every manufacturer claims to offer API “quality,” but for us, this is a commitment grounded in process transparency and traceable records.
Tablets and capsules demand APIs within a precise micron range. The wrong grind can cause content uniformity issues or even visible layer separation during tableting. For veterinary oral powders and granules, particle size distribution affects both suspension stability and flavor-masking, a practical concern for compliance. In premixes, especially those destined for large livestock operations, our API must survive handling in automated feed mills—a test many “herbal” APIs fail. Solutions and injectable forms expose another challenge: the Erythrinae Cortex extract must dissolve, disperse, and pass sterility testing, often at higher concentrations.
To serve these different needs, we manufacture several models—standardized to unique assays—by adjusting critical process parameters. For example, polysaccharide-rich fractions work better for high-dose oral powders, where mouthfeel and dispersibility guide animal acceptance. Lower-particle, highly purified API lots suit tablet compression lines, where flowability and absence of plant fiber residue make production faster and more predictable. Each format, whether a fine free-flowing powder for soft capsules or a sterile filtered concentrate for oral drench solutions, comes from feedback cycles with veterinary formulators and our own internal QC analytics, not just paperwork.
Production experience—more than machinery or paperwork—sets us apart. And field experience tells us, animal health integrators want more than a checkbox “herbal extract.” Analytic standards matter. We analyze each batch for alkaloid content using HPLC with CFR-compliant documentation. This focus reduces risk for animal health brands facing unpredictable sourcing issues as demand for botanical APIs rises worldwide. Customers ask about solubility, residue levels, and titration accuracy for creative inclusion rates across species. We provide clear, up-to-date data—drawn from our own batch logs—and work with partners to refine extraction methods if customer needs shift.
We also address concerns about non-active components—starch, residual cellulose, and trace metals. Each run passes a complete suite of impurity screens, including pesticide residue on all lots bound for solutions and injectables. Not every supplier shoulders this load: it requires in-house wet chemistry labs and skilled technicians who understand Erythrinae’s specific chemical fingerprint. Nothing goes to shipment until a signed-off certificate of analysis meets our own and the customer’s requirements, not just theoretical pharmacopoeia lines.
Many in this industry cut corners by simply trading in generic herbal powders. We see it too often—resellers buy dried bark on the spot market, run a simple ethanol extraction, and call it API. The result? Variability in animal response, unexplained side effects, and manufacturing headaches. We decided to do things differently: tight supply chain controls, validated assays for active components, and finished product simulation tests before batches leave our plant.
Other competitors sometimes tout “pharmacopoeial compliance” as if it guarantees performance. Compliance matters, but it is only the baseline. Real-world animal health depends on stability through distribution channels and finished dosage consistency. Our batches undergo stress and stability trials—refrigeration, freeze-thaw, and even simulated tropical humidity—so customers understand how the API holds up in real logistics scenarios. We share these findings directly, because nothing frustrates a feed mill operator more than a supposedly “shelf-stable” powder that clumps or loses color halfway through a regional summer.
We work with customers testing methanolic versus aqueous extracts for specific veterinary applications. Beef cattle, swine, and poultry have differing sensitivities and mass medication needs. Our technical staff talks directly to veterinary nutritionists and R&D leads to tailor extract strength, water content, and granulation. Direct communication—manufacturer to user—means formulas actually work in the barn, feedlot, or paddock, and not just on a QC report.
In practice, Erythrinae Cortex finds use in animal health on the strength of its traditional antispasmodic and mild sedative properties. Livestock handlers value it during transport and weaning stress, reducing reliance on synthetic tranquilizers which may leave residues or require withdrawal times. Companion animal veterinarians sometimes use products containing our API in formulations for chronic discomfort or to soothe excitable animals in clinical settings.
Each form—tablet, injection, capsule, powder, granule, premix, or solution—presents distinct challenges, and our team supports clients working out inclusion rates and API placement in multi-component formulas. Feed premixes, shipped in bulk, face months of transport in variable climates. Our staff tests APIs in prototypes replicating clients’ expected storage, so the final formula stays stable across long, multi-modal journeys from our plant to end-user barns. We use analytics to predict how particle size and extract ratio affect shelf life, relying on field feedback as much as in-house data.
For tablet and capsule production, we anticipate issues with blending loss, content uniformity, and API-excipient interaction. Our API comes with physical property data and recommendations for blending protocols. Film coating and pellet extrusion teams in integrated animal health groups rely on this level of support, and call us directly if an unforeseen caking or segregation issue crops up on a new line run. We see more customers shifting from straight powders to granulated or encapsulated mixtures, improving palatability and compliance without sacrificing batch integrity.
Global animal health regulations evolve quickly. Our veterinary customers need assurances not only of extract activity, but full traceability—often down to farm location for the Erythrina crop. We invest in digital records from field harvest to finished API, with yearly audits by third-party certifiers. Traceability audits slow down “gray market” products, but they also protect the end-user—farmers and animal health professionals—from contamination and fraud risk, ever-present with uncontrolled supply markets.
Every lot we deliver can be matched with a detailed chain of custody, from field clearances to final COA. If a veterinary brand owner faces import inspection at the border, paperwork matches each shipment. Our approach prevents disruptive recalls and import holds. Regulatory bodies in key markets now audit more frequently; transparency and documentation have become just as fundamental as chemistry. Unpredictable origin or inconsistent assay can damage reputations and restrict access, especially for brands exporting ready-to-use products containing our API. We invest upfront to clear these hurdles at the raw material stage.
Animal health group buyers want honesty and predictability. They see through buzzwords and empty certificates. Our production team stands ready to change extraction ratios or particle sizes in response to feedback from veterinary trials. If a batch shows unexpected dissolution in a powder blend, we tweak the drying protocol. If tablets show cracking, we run density checks and moisture control log updates. These changes require tight-knit collaboration between production and customers, and we prefer direct hands-on communication, not form emails.
We maintain a library of reference batches for each API variant, marked by date, process tweak, and outcome. If a customer calls with a concern about a specific product, our technical staff checks the actual retained sample, repeats any necessary assay, and provides direct answers. It keeps us accountable and ensures every improvement leaves a mark on future batches.
In reality, few APIs for veterinary use go straight from extraction to customer shipment without adjustment. We regularly slow or increase extraction times to maximize active alkaloid capture, then run pre-blending particle size checks for consistent content in finished forms. Sterilization steps for injectable batches require careful filtration and aseptic protocols, and each run is recorded and checked before packaging. A blocked filter or a failed sterility test holds up the line, and we never release a batch that does not meet our standards. Our staff approaches troubleshooting as an expected part of the craft, not an inconvenience.
Dealing with supply chain issues means holding more raw material stock than many resellers would accept. Drought in a growing region, flood during bark drying, or a shipping delay due to customs clearance can all disrupt timing for downstream animal health projects. We build detailed demand forecasts, purchase from farmers with known histories, and adjust order cycles based on regular communication with major veterinary brands.
As veterinary science advances, more health groups seek botanically-derived APIs alongside classic actives. Erythrinae Cortex serves as a bridge between the herbal wisdom of older veterinarians and the agnostic rigor of modern assay-literate teams. By refining the API’s chemical profile, reducing inactive ballast, and documenting trace components, we contribute not just an ingredient, but a transparent foundation for innovative animal health products.
Recent client requests include customization of extract ratios for reduced sediment in oral drench forms, simplified blinding for trials in pet species, and unique granule sizes for integration with pill presses unable to handle traditional herbal bulk. Each adjustment follows a strict process: a feed formulation trial, laboratory analytics, a technical review with customer supply staff, and a confirmatory minipilot in our plant, not a contract co-packer.
For customers focused on environmental responsibility, Erythrinae Cortex cultures leave a lighter resource footprint than many synthetic APIs. We publish water and energy use metrics with each batch. This allows animal health customers—especially large organizations with sustainability mandates—to back up marketing claims with real data.
As a manufacturer, we maintain accountability for every step from crop to dispatch dock. This is a promise of both chemistry and integrity. Our plant operators, laboratory staff, and QA managers do not see the API as a simple SKU. They see it as their output—an ingredient carrying their name and their reputation into barns, clinics, and laboratories around the world.
Unlike trading agents or generic resellers, we accept direct dialog and open books. If a veterinary client faces a product recall risk or reg requests a data update during a registration process, they do not find themselves routed through layers of middlemen. Our records, QC results, and improvement notes flow from our desks right into the hands of the people using—and sometimes testing—our API in actual animals.
Animal health supply chains serve living beings. Gaps in traceability, questionable assay data, or silent formulation issues can have real animal welfare consequences. Our philosophy holds that transparency and practical experience are inseparable. We encourage site visits, send out retained samples for customer comparison, and meet customer teams on the factory floor to walk through process updates or quality checks. This directness keeps us honest, improves the API year after year, and helps our partners deliver formulas that work—consistently, safely, and with full regulatory support.
We invest not just in machinery, but in the skill and judgment of our technical teams. New veterinary regulations, advances in animal nutrition theory, and changing consumer perceptions of herbal actives all shape our decisions in real time. Our doors are open to field feedback, and our logs record every change that improves quality, customer experience, or animal performance.
Veterinary brands relying on us do not just get a labeled drum or bag. They receive the results of hundreds of process refinements, dozens of direct customer trials, and a company philosophy fixed on supporting animal health with plant-derived solutions. This means complete records, living documentation, and a chain of support that adapts as science and field experience advance.
Our Erythrinae Cortex API for veterinary markets is not an off-the-shelf solution, but a grown, tested, and customer-validated component of modern animal health. Anyone seeking practical, real-world results in their finished dosage forms will find our team engaged, our documentation open, and our processes under continuous improvement—because we know that real animals, real farmers, and real veterinarians depend on the work we do, every day.